Yifan Pharmaceuticals
Yifan Pharmaceuticals, also known as Yifan Pharma, is a leading biopharmaceutical company headquartered in China (CN). Established in 2003, the company has made significant strides in the pharmaceutical industry, focusing on innovative drug development and advanced manufacturing processes. Yifan Pharmaceuticals operates primarily in the fields of oncology, cardiovascular diseases, and infectious diseases, offering a diverse portfolio of products that includes both generic and proprietary medications. With a commitment to quality and innovation, Yifan Pharmaceuticals has achieved notable milestones, including the successful development of advanced drug delivery systems. The company is recognised for its unique approach to biopharmaceuticals, positioning itself as a key player in the global market. Through its dedication to research and development, Yifan Pharmaceuticals continues to enhance its market presence and contribute to the advancement of healthcare solutions worldwide.
DitchCarbon Score
How does Yifan Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yifan Pharmaceuticals's score of 1 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yifan Pharmaceuticals's reported carbon emissions
Yifan Pharmaceuticals, headquartered in CN, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing sustainability practices. Yifan Pharmaceuticals may be engaging in similar efforts, but further information would be required to provide a comprehensive overview of their climate commitments and emissions profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yifan Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
